Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus

被引:27
作者
Jiménez-Alonso, J [1 ]
Osorio, JM [1 ]
Gutiérrez-Cabello, F [1 ]
de la Osa, AL [1 ]
León, L [1 ]
García, JDM [1 ]
机构
[1] Grp Lupus Virgen Nieves, Granada, Spain
关键词
D O I
10.1001/archinte.159.15.1811-a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1811 / 1812
页数:2
相关论文
共 5 条
[1]   An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor [J].
Black, DM ;
Bakker-Arkema, RG ;
Nawrocki, JW .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) :577-584
[2]   Choosing the right lipid-regulating agent - A guide to selection [J].
Farmer, JA ;
Gotto, AM .
DRUGS, 1996, 52 (05) :649-661
[3]   ACUTE HEPATITIS INDUCED BY HMG-COA REDUCTASE INHIBITOR, LOVASTATIN [J].
GRIMBERT, S ;
PESSAYRE, D ;
DEGOTT, C ;
BENHAMOU, JP .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (09) :2032-2033
[4]  
JACOTOT B, 1995, AM J CARDIOL, V76, pA41
[5]  
Pillans PI, 1996, NEW ZEAL MED J, V109, P315